Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MD PhD, Anna Sureda, MD PhD, Ana Pilar Gonzalez, MD, Fatima De la Cruz, MD PhD, Blanca Sanchez-Gonzalez, MD PhD, Antonia Rodriguez, MD PhD, Eva Domingo-Domenech, MD, Moreno Miriam, MD, Moreno Miriam, MD, Javier Lopez, Sr., MD PhD, Piñana Luis Jose, Gabriela Rodríguez, MD PhD, Miguel Canales, MD PhD, Antonio Gutierrez, MD PhD, Maria Dolores Caballero, MD PhD, Carmen Martinez, MD PhD

Blood (2016) 128 (22): 1109.

https://doi.org/10.1182/blood.V128.22.1109.1109

Published: 2016

Journal Articles

Procoagulant Profile of Platelets from Immune Thrombocytopenia Patients

María Teresa Álvarez Román, PhD, Raul Justo Sanz, BS Pharm, Elena Monzon Manzano, BSBC, Monica Martín Salces, MD, Ihosvany Fernandez Bello, PhD, Sergio Rivas Muñoz, BSBC, María Isabel Rivas Pollmar, MD, Miguel Canales, MD PhD, Victor Jiménez Yuste, PhD, Nora Butta, PhD

Blood (2016) 128 (22): 1370.

https://doi.org/10.1182/blood.V128.22.1370.1370

Published: 2016

Journal Articles

Haemostasis in Immune Trombocytopenia Patients Responders to Agonists of Thrombopoietin Receptor

Nora Butta, PhD, Ihosvany Fernandez Bello, PhD, María Teresa Álvarez Román, PhD, Monica Martín Salces, MD, Raul Justo Sanz, BS Pharm, Elena Monzon Manzano, BSBC, María Isabel Rivas Pollmar, MD, Sergio Rivas Muñoz, BSBC, Miguel Canales, MD PhD, Victor Jiménez Yuste, PhD

Blood (2016) 128 (22): 3743.

https://doi.org/10.1182/blood.V128.22.3743.3743

Published: 2016

Journal Articles

Early Detection of Chemotherapy- Induced Cardiotoxicity in Hematological Patients: A Prospective Study

Pilar Gómez-Prieto, MD, Teresa López, MD, Mar Moreno, Olaia Rodríguez, Elena Ramírez, Gema Casado, Antonio Buño, Jose Luis López- Sendón, MD PhD, Miguel Canales, MD PhD

Blood (2016) 128 (22): 5988.

https://doi.org/10.1182/blood.V128.22.5988.5988

Published: 2016

Journal Articles

Evaluation of Endothelial Damage in Sinusoidal Obstructive Syndrome

Nora Butta, PhD, Carmen de Ramón, MD, Raul Justo Sanz, BS Pharm, Elena Monzon Manzano, BSBC, Ihosvany Fernandez Bello, PhD, Mercedes Gasior, MD, Raquel De Paz, PhD, Karem Humala, MD, Pilar Gomez, MD, Ana Lopez de la Guia, MD, Marta Fabra, MD, Miguel Canales, MD PhD, Victor Jiménez Yuste, PhD

Blood (2016) 128 (22): 5802.

https://doi.org/10.1182/blood.V128.22.5802.5802

Published: 2016

Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Blood (2016) 128 (22): 4201.

https://doi.org/10.1182/blood.V128.22.4201.4201

Published: 2016

Journal Articles

Prognostic Factors and Treatment Results in Elderly Patients with Aggressive B-Cell Lymphoma: A Geltamo Observational Study

Blood (2015) 126 (23): 1508.

https://doi.org/10.1182/blood.V126.23.1508.1508

Published: 2015

Journal Articles

Platelet Functions and Risk Prognosis in Myelodysplastic Syndromes,

Nora V. Butta, PhD, Mónica Martín Salces, MD, Raquel de Paz, Elena G. Arias Salgado, PhD, Ihosvany Fernández Bello, Mayte Álvarez Román, MD, Isabel Rivas, MD, Miguel Canales, MD, PhD, Víctor Jiménez-Yuste, PhD

Blood (2011) 118 (21): 3806.

https://doi.org/10.1182/blood.V118.21.3806.3806

Published: 2011

Journal Articles

Haemostasis Assessed by Rotational Thromboelastometry and Thrombin Generation Test in Behcet's Disease Patients,

Ihosvany Fernández Bello, Elena G. Arias Salgado, PhD, Francisco Javier López-Longo, PhD, Mayte Álvarez Román, MD, Isabel Rivas, MD, Mónica Martín Salces, MD, Ana Gonzalez Vigo, PhD, Miguel Canales, MD, PhD, Víctor Jiménez-Yuste, PhD, Nora V. Butta, PhD

Blood (2011) 118 (21): 3313.

https://doi.org/10.1182/blood.V118.21.3313.3313

Published: 2011

Journal Articles

Fecal Calprotectin In Allogeneic Stem Cell Trasplantation as Surrogate Marker of Gastrointestinal Graft Versus Host Disease

Mariana Bastos Oreiro, MD, Ana Lopez de la Guia, MD, Jose B Nieto, MD, Raquel De Paz, MD, Patricia Baltasar, MD, Dolores Hernandez, MD, Ana Rodriguez de la Rua, MD, PhD, David Gallardo, MD, PhD, Miguel Canales, MD, PhD

Blood (2010) 116 (21): 2327.

https://doi.org/10.1182/blood.V116.21.2327.2327

Published: 2010

Journal Articles

Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.

Eva González-Barca, Miguel Canales, MD, PhD, María Jesús Vidal, Albert Oriol, Antonio Salar, Joan Bargay, Montse Cortés, Juan Coya, José Francisco Tomás, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero

Blood (2010) 116 (21): 2793.

https://doi.org/10.1182/blood.V116.21.2793.2793

Published: 2010

Journal Articles

First-Line Treatment with Rituximab Combined with Intravenous or Oral Fludarabine for Patients with Extranodal Mucosa Associated Lymphoid Tissue (MALT) Lymphoma.

Antonio Salar, MD, PhD, Eva Domingo-Domènech, MD, Cristina Estany, MD, Miguel Canales, MD, PhD, Octavio Servitge, MD, Fernando Gallardo, MD, PhD, Guadalupe Fraile, Carlos Montalbán, PHD

Blood (2008) 112 (11): 2007.

https://doi.org/10.1182/blood.V112.11.2007.2007

Published: 2008

NARROW

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Procoagulant Profile of Platelets from Immune Thrombocytopenia Patients

Haemostasis in Immune Trombocytopenia Patients Responders to Agonists of Thrombopoietin Receptor

Early Detection of Chemotherapy- Induced Cardiotoxicity in Hematological Patients: A Prospective Study

Evaluation of Endothelial Damage in Sinusoidal Obstructive Syndrome

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Prognostic Factors and Treatment Results in Elderly Patients with Aggressive B-Cell Lymphoma: A Geltamo Observational Study

Platelet Functions and Risk Prognosis in Myelodysplastic Syndromes,

Haemostasis Assessed by Rotational Thromboelastometry and Thrombin Generation Test in Behcet's Disease Patients,

Fecal Calprotectin In Allogeneic Stem Cell Trasplantation as Surrogate Marker of Gastrointestinal Graft Versus Host Disease

Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.

First-Line Treatment with Rituximab Combined with Intravenous or Oral Fludarabine for Patients with Extranodal Mucosa Associated Lymphoid Tissue (MALT) Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only